|
|||||
|
|
Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity” |
|
| Authors: | E. J. Gane K. Agarwal |
| Affiliation: | 1. New Zealand Liver Transplant Unit, Auckland City Hospital, , Auckland, New Zealand;2. Institute of Liver Studies, King's College Hospital, , London, UK |
| Abstract: | |
| Keywords: | Boceprevir fibrosis hepatitis C virus ledipasvir liver transplantation low accelerating dose regimen pegylated interferon ribavirin sofosbuvir telaprevir |